1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FD9F7C25A463007C85256E360064D0FD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/clinical-operations-managing-research-grant-requests?opendocument
18
19opendocument
203.237.38.244
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Research and Development Communications

Clinical Operations: Managing Research Grant Requests

DB Image

ID: 4553


Features:

Metrics, Graphics, Summary Matrix, Detailed Process Map


Published: Pre-2016


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Based on a survey of eight leading pharmaceutical organizations, this 15-slide presentation examines how pharmaceutical companies manage unsolicited research grant requests from investigators. Key topic areas in this study include: research request channels, research approval processes, tracking research completion and milestone requirements for payment. Companies can use this information to evaluate their process for managing unsolicited research grant requests.

The study found that companies' research request approval process have varying levels of complexity. For example, some organizations have designated committees and processes for ranking and evaluating requests, while others operate under an ad-hoc or less-complex approval system.

Companies use an average of two separate requirements to track research completion: abstract reviews and
research reports. Additionally, 75% require some sort of collateral or research milestone before payment.

This information was collected from Best Practices, LLC Internet Benchmarking Exchange service.

Industries Profiled:
Biotech; Pharmaceutical; Chemical; Manufacturing; Consumer Products; Diagnostic; Medical Device


Companies Profiled:
Amgen; Almirall; Solvay America; TTY Biopharm; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; Millenium

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.